• ERT and Bioclinica are now Clario. Find out more about our new name, and why we have come together.

Your using an unsupported browser. Please update to a modern browser for a better experience.

Cardiac safety concerns are among the leading reasons that promising drugs are delayed or abandoned. We offer a range of options tailored to your compound, site locations and ever-changing regulatory requirements.

Product detail

Patch Arrhythmia

  • Leveraging our deep Holter arrhythmia knowledge combined with more patient-friendly devices, Clario provides global logistics and clinical trial quality data. We have flexible options for recording durations up to 14 days and offer wire-free single and dual channel recording options. 

Holter Arrhythmia

  • Continuous 12 lead ECG Holter solution to produce detailed data for 24-48hr increments
  • Over 40 years of experience in Holter arrhythmia analysis enables Clario to provide the most consistent, reliable arrhythmia data
Male medicine doctor hands holding cardiogram chart

Phase I/TQT Assessment

Fulfill your ICH E14 requirement early, minimize risk and potentially reduce costs throughout your trial by collaborating with our Phase 1 Center of Excellence.

Doctor hands with cardiogram chart

ECG – Phase I – IV

Monitor every heartbeat with precision and ensure safety throughout your entire clinical trial.

Doctor using sphygmomanometer to check body pressure and pulse of patient

Blood Pressure Services

Collect accurate, reliable blood
pressure data with consistent devices
and centralized data analysis.

People looking at iMac Spreadsheet

Regulatory Consultation and Statistical Analysis Services

Leverage our industry key opinion leaders to understand the complex regulatory landscape while minimizing risk with confidence.

Learn more or speak with one our experts

Our team of clinical trial cardiac safety experts is always available to address any questions you may have about our cardiac safety solutions. Submit your contact information and we’ll be in touch shortly.